Dow Gains 40 Points As Healthcare Stocks Outperform
New York: The S&P 500 and Nasdaq Composite fell on Monday after six sessions of gains, weighed by tech sector stocks, while a rally in energy shares petered out as crude oil gains withered.
Bank shares fell ahead of the Federal Reserve's last meeting for the year, set to begin Tuesday and expected to end on Wednesday with the year's first interest rate increase.
Traders cashed in gains in bank stocks ahead of the meeting, even if a rate hike, which on paper would benefit banks, is all but priced in.
The chances that the US central bank will not raise rates is "close to zero, but it's not zero", said Kim Forrest, senior equity research analyst at Fort Pitt Capital Group in Pittsburgh.
The S&P 500 financial sector fell 0.9 per cent following five consecutive weeks of gains.
The benchmark's tech sector fell 0.5 per cent after posting its largest weekly advance in a year last week.
The healthcare sector was the biggest boost to both the S&P 500 and the Dow industrials.
Regeneron gained 3.8 per cent to $387.10 after data on a competing drug combination from Novartis and Opthotech did not meet its main goal. Ophthotech shares tumbled 86.4 per cent.
Regeneron was the largest percentage gainer on both the S&P 500 and the Nasdaq 100.
The Dow Jones industrial average rose 39.58 points, or 0.2 per cent, to 19,796.43, the S&P 500 lost 2.57 points, or 0.11 per cent, to 2,256.96 and the Nasdaq Composite dropped 31.96 points, or 0.59 per cent, to 5,412.54.
The Dow posted the latest in a string of record closing highs.
Energy stocks on the S&P 500 rose as much as 2.5 per cent in early trading as crude oil prices soared around 6 per cent to levels not seen in a year and a half. The sector ended up 0.7 per cent, with both WTI and Brent crude barrels up less than 2 per cent.
The industrials sector was down 0.37 per cent, dragged down by defence stocks. Lockheed Martin declined 2.5 per cent to $253.11, bouncing back from a session low of $245.50, after US President-elect Donald Trump tweeted that the company's F-35 program and costs were "out of control".
Viacom fell 9.4 per cent to $34.99. National Amusements withdrew its merger proposal for CBS and Viacom. Privately-held National Amusements is controlled by Sumner Redstone and his daughter, Shari Redstone.
Alexion Pharmaceuticals fell 12.9 per cent to $115.08. The chief executive officer and chief financial officer resigned, a month after the drug maker said it was investigating allegations related to sales practices of its flagship drug.
Declining issues outnumbered advancing ones on the NYSE by a 1.79-to-1 ratio; on Nasdaq, a 2.23-to-1 ratio favored decliners.
About 7.4 billion shares changed hands in US exchanges, roughly in line with the average volume over the last 20 sessions.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.